Editorial board

Mary Beth Genter, PhD University of Cincinnati, USA

Bruce K. Bernard, PhD SRA Consulting, Cambridge, MD, USA
Marion F. Ehrich, PhD VA-MD Regional College of Veterinary Medicine, Blacksburg, VA, USA
Donald G. Stump, PhD Charles River, Ashland, OH, USA

Robert W. Kapp, Jr., PhD BioTox, Stafford Township, NJ, USA

Krishna P. Allamneni, PhD Concarlo Therapeutics, Inc., Brooklyn, NY, USA
Shana Azri-Meehan, PhD Cardinal Health, Millington, NJ, USA
Theodore J. Baird, PhD Charles River, Mattawan, MI, USA
Lisa D. Beilke, PhD Toxicology Solutions, Inc., San Diego, CA, USA
Susan Borghoff, PhD ToxStrategies, Inc., Cary, NC, USA
William J. Brock, PhD Brock Scientific Consulting, Montgomery, MD
Alan P. Brown, PhD Novartis Institutes for BioMedical Research, Cambridge, MA, USA
Lorrene A. Buckley, PhD Eli Lilly and Company, Indianapolis, IN, USA
John A. Budny, PhD PharmaCal, Redding, CA, USA
Florence G. Burleson, PhD BRT-Burleson Research Technologies, Inc., Morrisville, NC, USA
Gary R. Burleson, PhD BRT-Burleson Research Technologies, Inc., Morrisville, NC, USA
Leigh Ann Burns Naas, PhD Magnolia Toxicology Consulting, LLC, Traverse City, MI, USA
Erica Carroll, DVM, PhD Covance, Greenfield, IN, USA
Charleata Carter, PhD Carter Consulting, Greensboro, NC, USA
Scott Coleman, PhD Acceleron, Attleboro, MA, USA
David Compton, PhD Annandale, NJ, USA
Mary Ellen Cosenza, MEC Regulatory & Toxicology Consulting, LLC, Moorpark, CA, USA
Matthew Z. Dieter, PhD Eli Lilly and Company, Indianapolis, IN, USA
Sandy Eldridge, PhD National Cancer Institute, NIH, Bethesda, MD, USA
Li-jie Fu, PhD Shin Nippon Biomedical Labs, Ltd, Beijing, China
Shayne C. Gad, PhD Gad Consulting Services, Cary, NC, USA
Hanan N. Ghantous, PhD US FDA, Silver Spring, MD, USA
Robin C. Guy, MS Robin Guy Consulting, LLC, Lake Forest, IL, USA
Bert Haenen, PhD Janssen Research and Development, Beerse, Belgium
Jerry F. Hardisty EPL Inc., Research Triangle Park, NC, USA
Stephen B. Harris, PhD Stephen B. Harris Group, San Diego, CA, USA
Alan M. Hoberman, PhD Charles River, Horsham, PA, USA
David W. Hobson, PhD LoneStar PharmTox LLC, Boerne, TX, USA
Debie Hoivik, PhD Akebia Therapeutics, Cambridge, MA, USA
Heidi Hsieh, PhD Covance, Madison, WI, USA
Elaine V. Knight, PhD National Cancer Institute, NIH, Bethesda, MD, USA
Stephen B. Montgomery, PhD Consulting Nonclinical Safety Assessment, Alpharetta, GA, USA
P. Balakrishna Murthy, PhD, DSc Consultant Toxicologist, Chennai, India
Kenneth J. Olivier, Jr., PhD Morphic Therapeutics, Attleboro, MA, USA
Madhav Paranjpe, DVM, PhD Charles River, Mattawan, MI, USA
Charles W. Qualls, Jr., DVM, PhD Thousand Oaks, California, USA
Gunda Reddy, PhD Fallston, MD, USA
Robert Roy, PhD Northland Toxicology Consultants, LLC, MN, USA
Alan H. Stokes, PhD GSK, Rockville, MD, USA
Tao Wang, MD, PhD Coherus BioSciences, Redwood City, CA, USA
Adam Woolley, MSc, FRCPath ForthTox Ltd., Linlithgow, Scotland, UK
David Woolley, PhD Forthtox, Ltd., Linlithgow, Scotland